Agelity® D-Pinitol: New Peer-Reviewed Research in Brain Health

Published in the British Journal of Pharmacology, this study reveals that Agelity® reduces tau hyperphosphorylation by regulating CDK5 activity, supporting its role as a science-driven nutraceutical approach for tau-related neurodegeneration and cognitive aging.